Approval · Notice of Compliance 1457 · 2000
SCHEINPHARM RANITIDINE: Notice of Compliance 1457
Issued February 23, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1457
- Date
- February 23, 2000
- Company
- Schein Pharmaceutical Canada Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Histamine H2 receptor antagonist
- Canadian reference product
- ZANTAC (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SCHEINPHARM RANITIDINE | 02241597 | — |
| SCHEINPHARM RANITIDINE | 02241598 | Cancelled Post Market |
| SCHEINPHARM RANITIDINE | 02241599 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB